Six ASBMB members elected to NAM
The National Academy of Medicine has elected a class of 100 new members, including six members of the American Society for Biochemistry and Molecular Biology. These new NAM members are exceptional scholars who have demonstrated outstanding professional achievement and commitment to service. The ASBMB members among the honorees are Craig Blackstone, Namandjé Bumpus, Peter Glazer, Laura Kiessling, Lisa Monteggia and Yang Shi.
These 2022 elections bring NAM’s total membership to more than 2,200, including 190 international members.
Craig Blackstone, chief of the movement disorders division in the neurology department at Massachusetts General Hospital and professor of neurology at Harvard Medical School, was recognized for identifying the cellular pathogenic mechanisms underlying hereditary spastic paraplegia and providing insight into the basic biology of the endoplasmic reticulum.
Namandjé Bumpus, chief scientist at the U.S. Food and Drug Administration and a professor of pharmacology at Johns Hopkins University School of Medicine, was recognized for foundational work in drug metabolism and antiviral pharmacology as well as translating fundamental drug metabolism studies to the prediction of patient drug responses.
Peter Glazer, professor and chair of therapeutic radiology at Yale School of Medicine, was recognized for discovering that tumor hypoxia causes genetic instability and IDH1 mutations suppress DNA repair in cancers, which cause vulnerability to radiation and PARP inhibitors. Glazer has developed novel drugs for cancer and gene editing, which has led to multiple cancer clinical trials.
Laura Kiessling, professor of chemistry at the Massachusetts Institute of Technology, was recognized for fundamental discoveries of protein-glycan interactions pertinent to immunity, inflammation, host-microbe interactions and human development.
Lisa Monteggia, professor of pharmacology at Vanderbilt University, was recognized for contributions to the neurobiology of emotion, pioneering work identifying a causal link between neurotrophin signaling and antidepressant action, and contributions to understanding the synaptic plasticity mechanisms underlying the therapeutic effects of psychiatric treatments.
Yang Shi, professor and director of epigenetics at Oxford University and a member of the Ludwig Institute for Cancer Research, was recognized for the groundbreaking discovery that histone methylation is reversible and discovery of the first histone demethylase.
Enjoy reading ASBMB Today?
Become a member to receive the print edition four times a year and the digital edition weekly.
Learn moreGet the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in People
People highlights or most popular articles
Computational and biophysical approaches to disordered proteins
Rohit Pappu will receive the 2025 DeLano Award for Computational Biosciences at the ASBMB Annual Meeting, April 12-15 in Chicago.
Join the pioneers of ferroptosis at cell death conference
Meet Brent Stockwell, Xuejun Jiang and Jin Ye — the co-chairs of the ASBMB’s 2025 meeting on metabolic cross talk and biochemical homeostasis research.
Helping underrepresented scientists feel seen
Benjamin Garcia will receive the ASBMB Ruth Kirschstein Diversity in Science Award at the ASBMB Annual meeting, April 12–15 in Chicago.
Honors for Emr, Sundquist, Ohm and Szoo
Scott Emr and Wesley Sundquist won the 2024 Louisa Gross Horwitz Prize. Adam Ohm and Madeline Szoo have been awarded scholarships by the Fellowship Board of Tau Beta Pi.
In memoriam: Bengt Samuelsson
He was a Nobel laureate, a professor at the Karolinska Institute, a lipid biochemist and an ASBMB member for almost 50 years.
A scientist's journey through disability, grad school, and beyond
By the end of high school, Crystal Mendoza already had lab experience and was well on her way to a college degree and a promising future. All the bumps in her road lay ahead.